ONCOIMMUNE, INC.

Organization

ROCKVILLE, MD, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods of use of CD24 for the prevention and treatment of leukemia...
- Patent number 11,911,441
- Issue date Feb 27, 2024
- Oncoimmune, Inc.
- Yang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of use of soluble CD24 for treating lupus nephritis
- Patent number 11,571,461
- Issue date Feb 7, 2023
- Oncoimmune, Inc.
- Yang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of CD24 proteins for treating leptin-deficient conditions
- Patent number 10,799,558
- Issue date Oct 13, 2020
- Oncoimmune, Inc.
- Yang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of use of soluble CD24 for therapy of rheumatoid arthritis
- Patent number 10,793,617
- Issue date Oct 6, 2020
- Oncoimmune, Inc.
- Xincheng Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric and humanized anti-human CTLA4 monoclonal antibodies and u...
- Patent number 10,618,960
- Issue date Apr 14, 2020
- Oncoimmune, Inc.
- Yang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of CD24 for lowering low-density lipoprotein cholesterol levels
- Patent number 10,369,197
- Issue date Aug 6, 2019
- Oncoimmune, Inc.
- Yang Liu
- G01 - MEASURING TESTING
Information Patent Grant
Uses of hypoxia-inducible factor inhibitors
- Patent number 9,877,998
- Issue date Jan 30, 2018
- Oncoimmune, Inc.
- Yang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Uses of hypoxia-inducible factor inhibitors
- Patent number 9,427,413
- Issue date Aug 30, 2016
- Oncoimmune, Inc.
- Yang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of use of soluble CD24 for therapy of rheumatoid arthritis
- Patent number 8,895,022
- Issue date Nov 25, 2014
- Oncoimmune, Inc.
- Xincheng Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of use of soluble CD24 for therapy of rheumatoid arthritis
- Patent number 8,808,697
- Issue date Aug 19, 2014
- Oncoimmune, Inc.
- Xincheng Zheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF USE OF SOLUBLE CD24 FOR TREATING SYSTEMIC LUPUS ERYTHEMA...
- Publication number 20220125874
- Publication date Apr 28, 2022
- OncoImmune, Inc.
- Yang LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USE OF CD24 FOR THE PREVENTION AND TREATMENT OF LEUKEMIA...
- Publication number 20210268061
- Publication date Sep 2, 2021
- OncoImmune, Inc.
- Yang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USE OF CD24 FOR THE PREVENTION AND TREATMENT OF GRAFT VE...
- Publication number 20210228680
- Publication date Jul 29, 2021
- OncoImmune, Inc.
- Yang LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD24 COMPOSITIONS AND USES THEREOF
- Publication number 20210214458
- Publication date Jul 15, 2021
- OncoImmune, Inc.
- Yang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of CD24 Proteins for Treating Leptin-Deficient Conditions
- Publication number 20210162006
- Publication date Jun 3, 2021
- OncoImmune, Inc.
- Yang LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
- Publication number 20210161991
- Publication date Jun 3, 2021
- OncoImmune, Inc.
- Yang LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USE OF SOLUBLE CD24 FOR TREATING ACQUIRED IMMUNE DEFICIE...
- Publication number 20210046154
- Publication date Feb 18, 2021
- OncoImmune, Inc.
- Yang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS
- Publication number 20200399345
- Publication date Dec 24, 2020
- OncoImmune, Inc.
- Xincheng Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chimeric and Humanized Anti-Human CTLA4 Monoclonal Antibodies and U...
- Publication number 20200283526
- Publication date Sep 10, 2020
- OncoImmune, Inc.
- Yang LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USE OF SOLUBLE CD24 FOR TREATING IMMUNE RELATED ADVERSE...
- Publication number 20200197485
- Publication date Jun 25, 2020
- OncoImmune, Inc.
- Yang LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USE OF SOLUBLE CD24 FOR NEUROPROTECTION AND REMYELINATION
- Publication number 20200181235
- Publication date Jun 11, 2020
- OncoImmune, Inc.
- Yang LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
- Publication number 20200147167
- Publication date May 14, 2020
- OncoImmune, Inc.
- Yang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF CD24 FOR LOWERING LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS
- Publication number 20190307841
- Publication date Oct 10, 2019
- OncoImmune, Inc.
- Yang LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD80 and CD86 Binding Protein Compositions and Uses Thereof
- Publication number 20190263889
- Publication date Aug 29, 2019
- OncoImmune, Inc.
- Yang LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
- Publication number 20190255140
- Publication date Aug 22, 2019
- OncoImmune, Inc.
- Yang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chimeric and Humanized Anti-Human CTLA4 Monoclonal Antibodies and U...
- Publication number 20190127468
- Publication date May 2, 2019
- OncoImmune, Inc.
- Yang LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of CD24 Proteins for Treating Leptin-Deficient Conditions
- Publication number 20190038716
- Publication date Feb 7, 2019
- OncoImmune, Inc.
- Yang LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
- Publication number 20180177841
- Publication date Jun 28, 2018
- OncoImmune, Inc.
- Yang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF CD24 FOR LOWERING LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS
- Publication number 20180110828
- Publication date Apr 26, 2018
- OncoImmune, Inc.
- Yang LIU
- G01 - MEASURING TESTING
Information Patent Application
USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
- Publication number 20170239315
- Publication date Aug 24, 2017
- OncoImmune, Inc.
- Yang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS
- Publication number 20170233453
- Publication date Aug 17, 2017
- OncoImmune, Inc.
- Xincheng Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
- Publication number 20170035832
- Publication date Feb 9, 2017
- OncoImmune, Inc.
- Yang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS
- Publication number 20130136739
- Publication date May 30, 2013
- ONCOIMMUNE, INC.
- Xincheng Zheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
- Publication number 20120264697
- Publication date Oct 18, 2012
- ONCOIMMUNE INC.
- Yang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
90221101 - ONCOIMMUNE
- Serial number 90221101
- Filing date Sep 29, 2020
- OncoImmune, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90221098 - ONCOIMMUNE
- Serial number 90221098
- Filing date Sep 29, 2020
- OncoImmune, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90187540 - SACCOVID
- Serial number 90187540
- Filing date Sep 17, 2020
- OncoImmune, Inc.
- 44 - Medical services

ONCOIMMUNE, INC.

Organization

Patents Grantslast 30 patents

Methods of use of CD24 for the prevention and treatment of leukemia...

Methods of use of soluble CD24 for treating lupus nephritis

Use of CD24 proteins for treating leptin-deficient conditions

Methods of use of soluble CD24 for therapy of rheumatoid arthritis

Chimeric and humanized anti-human CTLA4 monoclonal antibodies and u...

Use of CD24 for lowering low-density lipoprotein cholesterol levels

Uses of hypoxia-inducible factor inhibitors

Uses of hypoxia-inducible factor inhibitors

Methods of use of soluble CD24 for therapy of rheumatoid arthritis

Methods of use of soluble CD24 for therapy of rheumatoid arthritis

Patents Applicationslast 30 patents

METHODS OF USE OF SOLUBLE CD24 FOR TREATING SYSTEMIC LUPUS ERYTHEMA...

METHODS OF USE OF CD24 FOR THE PREVENTION AND TREATMENT OF LEUKEMIA...

METHODS OF USE OF CD24 FOR THE PREVENTION AND TREATMENT OF GRAFT VE...

ANTI-CD24 COMPOSITIONS AND USES THEREOF

Use of CD24 Proteins for Treating Leptin-Deficient Conditions

USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

METHODS OF USE OF SOLUBLE CD24 FOR TREATING ACQUIRED IMMUNE DEFICIE...

METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS

Chimeric and Humanized Anti-Human CTLA4 Monoclonal Antibodies and U...

METHODS OF USE OF SOLUBLE CD24 FOR TREATING IMMUNE RELATED ADVERSE...

METHODS OF USE OF SOLUBLE CD24 FOR NEUROPROTECTION AND REMYELINATION

USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

USE OF CD24 FOR LOWERING LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS

CD80 and CD86 Binding Protein Compositions and Uses Thereof

USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

Chimeric and Humanized Anti-Human CTLA4 Monoclonal Antibodies and U...

Use of CD24 Proteins for Treating Leptin-Deficient Conditions

USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

USE OF CD24 FOR LOWERING LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS

USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS

USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS

USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

Trademarklast 30 trademarks

90221101 - ONCOIMMUNE

90221098 - ONCOIMMUNE

90187540 - SACCOVID